Results 141 to 150 of about 101,616 (361)

Clinical progress note: Hepatitis A virus

Journal of Hospital Medicine, EarlyView.
Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors ...
James M. McCluskey III, Robyn A. Bockrath, Ravi Jhaveri   +2 more
wiley   +1 more source

Sequence analysis of sub-genotype D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia. [PDF]

Saudi J Biol Sci, 2018
El Hadad S, Alakilli S, Rabah S, Sabir J.   +3 more
europepmc   +1 more source

Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers

, 1977
G. Arnold, J W Shih, Peter Kaplán, R H Purcell, John L. Gerin, K H Meyer Zum Bueschenfelde   +5 more
openalex   +1 more source

Glycoproteins of natural origin with an affinity for hepatitis B surface antigen [PDF]

, 1978
Irving Millman, John McMichael
openalex   +1 more source

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigates the impact of cardiometabolic risk factors (CMRF) on the prevalence and incidence of hypertension (HTN) and diabetes mellitus (DM) in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and nonsteatotic liver disease (non‐SLD), using both cross‐sectional and longitudinal data. A total of 32,
Chin‐I Shih, Ming‐Lun Yeh, Yi‐Hung Lin, Ping‐Tsung Shih, Kuan‐Ta Wu, Meng‐Hsuan Hsieh, Jeng‐Fu Yang, Yi‐Yu Chen, Po‐Cheng Liang, Yu‐Ju Wei, Pei‐Chien Tsai, Ya‐Yun Cheng, Ming‐Yen Hsieh, Chih‐Wen Wang, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Chi‐Kung Ho, Wan‐Long Chuang, Vincent Wai‐Sun Wong, Wei‐Ting Chang, Ming‐Lung Yu   +21 more
wiley   +1 more source

Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant

Human Vaccines & Immunotherapeutics
Archaeosomes are liposomes traditionally comprised of total polar lipids or semi-synthetic glycerolipids of ether-linked isoprenoid phytanyl cores with varied glycol- and amino-head groups. We have developed a semi-synthetic archaeosome formulation based
Bassel Akache, Michael J. McCluskie
doaj   +1 more source

Solid-phase enzyme immunoassay for hepatitis B surface antigen.

, 1977
R Wei, G J Knight, D H Zimmerman, H E Bond   +3 more
openalex   +1 more source

Detection, by three techniques, of hepatitis B surface antigen (HBsAg) and determination of HBsAg and anti-HBs titres in patients with chronic liver disease. [PDF]

, 1977
M. Chiaramonte, Jenny Heathcote, Megan Crees, S. Sherlock   +3 more
openalex   +1 more source

The Serumal Concentration of Hbsag in Patiets with Chb/hiv Co-infection Comparing with Chb Mono-infection in the Different Phases of Natural Course of Chronic Hepatitis В [PDF]

, 2016
The prevalence and inclination to chronization of viral hepatitis B is 3 – 5 times higher in patients with HIV-infection than in HIV-negative ones. The natural clinical course of chronic hepatitis B (CHB) in patients with HIV has the features, connected ...
Melnyk, T. (Tetiana), Moroz, L. (Larisa)
core  

New technique for solid-phase immunoassay: application to hepatitis B surface antigen. [PDF]

, 1979
Hyunsun Park
openalex   +1 more source